“Nobody wants to stick a needle into their body unless they have to.” – Jokke Mäki, CEO, GlucoModicum
Click here for a free trial of Medtech Insight
QUOTED. 30 April 2021. Jeff Mäki
Listen to this article
Finnish-based GlucoModicum is developing a painless, needle-free glucose-monitoring device that looks like a smartwatch to make managing pre-diabetes and undertreated type 2 diabetes more convenient. See what the CEO, Jeff Mäki, said about it here.
Keep up with the top medtech business and regulatory news.
More from Startups & SMEs
• By
Spain has one of the highest incarceration rates in Europe, with 160 individuals imprisoned per 100,000 residents. In 2020, 43,494 people were incarcerated in facilities not managed by regional health authorities — essentially all regions except Catalonia, the Basque Country, and Navarra.
• By
The Acton, MA-based tubeless insulin pump specialist expands its indication for the Omnipod 5 AID system beyond type 1 diabetes as FDA authorization for type 2 comes sooner than Wall Street expected. Analysts expect clearances of rival systems from Tandem Diabetes Care and Medtronic in 2025, but believe Insulet is well-positioned to compete.
• By
Two years after the EU adopted the original common specifications for certain products under the IVD Regulation, the commission has added new products and updated its requirements.
• By
Hello Heart has introduced a symptom tracking feature in its app, allowing users to log feelings of dizziness or shortness of breath in conjunction with blood pressure readings. The enhancement will help all users to monitor cardiovascular risks, but women in particular could benefit, the company suggests.
More from Business
This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.